Skip to main content

Centessa Pharmaceuticals plc

CNTADelisted Jun 24, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001847903

Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.

13F holders, Q2 2023

Institutional positions in Centessa Pharmaceuticals plc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
45
+1 vs. Q1 2023
Shares held
70.3M
+3.45M (+5.2%) vs. Q1 2023
Total value
$435.4M
+$177.9M (+69.1%) vs. Q1 2023
New holders
5
15 more added
Sold out
4
7 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 45 institutions
Q1 2021: 0 institutionsQ2 2021: 50 institutionsQ3 2021: 40 institutionsQ4 2021: 47 institutionsQ1 2022: 44 institutionsQ2 2022: 41 institutionsQ3 2022: 44 institutionsQ4 2022: 44 institutionsQ1 2023: 44 institutionsQ2 2023: 45 institutionsQ3 2023: 49 institutionsQ4 2023: 58 institutionsQ1 2024: 69 institutionsQ2 2024: 80 institutionsQ3 2024: 103 institutionsQ4 2024: 114 institutionsQ1 2025: 130 institutionsQ2 2025: 117 institutionsQ3 2025: 125 institutionsQ4 2025: 147 institutionsQ1 2026: 161 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $435.4M
Q1 2021: $0Q2 2021: $1.05BQ3 2021: $947.5MQ4 2021: $807.8MQ1 2022: $669.1MQ2 2022: $350.3MQ3 2022: $288.7MQ4 2022: $194.4MQ1 2023: $257.5MQ2 2023: $435.4MQ3 2023: $469.6MQ4 2023: $567.4MQ1 2024: $840.7MQ2 2024: $781.2MQ3 2024: $1.74BQ4 2024: $2.08BQ1 2025: $1.80BQ2 2025: $1.62BQ3 2025: $3.11BQ4 2025: $3.60BQ1 2026: $5.90BQ2 2026: $0
Institutions holding CNTA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 2026161$5.90B
Q4 2025147$3.60B
Q3 2025125$3.11B
Q2 2025117$1.62B
Q1 2025130$1.80B
Q4 2024114$2.08B
Q3 2024103$1.74B
Q2 202480$781.2M
Q1 202469$840.7M
Q4 202358$567.4M
Q3 202349$469.6M
Q2 202345$435.4M
Q1 202344$257.5M
Q4 202244$194.4M
Q3 202244$288.7M
Q2 202241$350.3M
Q1 202244$669.1M
Q4 202147$807.8M
Q3 202140$947.5M
Q2 202150$1.05B
Q1 20210$0

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q1 2023.

Institutions holding CNTA in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Medicxi Ventures Management (Jersey) Ltd19,963,157$123.6M34.62%00.0%Unchanged
General Atlantic LLC9,681,818$59.9M0.94%00.0%Unchanged
BVF Inc9,423,215$58.3M1.63%00.0%Unchanged
EcoR1 Capital, LLC5,618,779$34.8M0.92%00.0%Unchanged
Vida Ventures Advisors, LLC3,931,818$24.3M31.78%00.0%Unchanged
OUP Management Co., LLC2,937,615$18.2M31.01%00.0%Unchanged
FMR LLC2,787,194$17.3M0.00%+1,556,285+126.4%Added
Price T Rowe Associates Inc2,363,211$14.6M0.00%+49,778+2.2%Added
Adage Capital Partners GP, L.L.C.2,250,000$13.9M0.03%+2,250,000New
Point72 Asset Management, L.P.2,011,388$12.5M0.04%+235,906+13.3%Added
Boxer Capital, LLC1,251,137$7.75M0.36%00.0%Unchanged
Affinity Asset Advisors, LLC900,723$5.58M2.19%+216,596+31.7%Added
Sio Capital Management, LLC877,193$5.43M1.92%+529,324+152.2%Added
Franklin Resources Inc832,348$5.15M0.00%00.0%Unchanged
Morgan Stanley824,629$5.10M0.00%+80,722+10.9%Added
Kynam Capital Management, LP729,077$4.51M0.69%00.0%Unchanged
Tanager Wealth Management LLP696,096$4.31M0.93%−40,963−5.6%Reduced
American Century Companies Inc694,862$4.30M0.00%+180,746+35.2%Added
Woodline Partners LP687,763$4.26M0.05%−48,230−6.6%Reduced
Cormorant Asset Management, LP561,600$3.48M0.20%00.0%Unchanged
Octagon Capital Advisors LP411,928$2.55M0.36%+15,928+4.0%Added
BlackRock Inc.294,500$1.82M0.00%+1,840+0.6%Added
Platinum Investment Management Ltd171,625$1.06M0.04%+171,625New
Ensign Peak Advisors, Inc125,157$774.7K0.00%00.0%Unchanged
TD Asset Management Inc82,055$507.9K0.00%00.0%Unchanged
JPMorgan Chase & Co59,364$367.5K0.00%−39,861−40.2%Reduced
Manufacturers Life Insurance Company, The57,421$355.4K0.00%00.0%Unchanged
Renaissance Technologies LLC34,300$212.0K0.00%+18,600+118.5%Added
Geode Capital Management, LLC25,120$155.5K0.00%+2,434+10.7%Added
Two Sigma Investments, LP11,100$68.7K0.00%+11,100New
Goldman Sachs Group Inc10,650$65.9K0.00%−310−2.8%Reduced
Barclays PLC6,400$39.6K0.00%00.0%Unchanged
Compagnie Lombard Odier SCmA5,820$36.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)4,272$26.4K0.00%−4,302−50.2%Reduced
Bank of America Corp4,211$26.1K0.00%+2,926+227.7%Added
Citadel Advisors LLC4,105$25.4K0.00%+4,105New
Advisor Group Holdings, Inc.3,176$19.7K0.00%+431+15.7%Added
UBS Group AG2,118$13.1K0.00%−3,045−59.0%Reduced
Adirondack Trust Co925$7.31K0.00%00.0%Unchanged
Citigroup Inc895$5.54K0.00%+294+48.9%Added
Global Retirement Partners, LLC700$4.33K0.00%00.0%Unchanged
China Universal Asset Management Co., Ltd.691$4.28K0.00%−21−2.9%Reduced
Daiwa Securities Group Inc.211$1.00K0.00%00.0%Unchanged
Royal Bank of Canada185$1.00K0.00%+115+164.3%Added
Simplex Trading, LLC38$00.00%+38New
Samsara BioCapital, LLC0$00.00%−1,693,736−100.0%Sold out
Jane Street Group, LLC0$00.00%−40,238−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−12,616−100.0%Sold out
Crewe Advisors LLC0$00.00%−220−100.0%Sold out